DOCSLIB.ORG

The Evolution of Corneal Transplantation Published: 2017.12.15

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

ORIGINAL PAPER e-ISSN 2329-0358 © Ann Transplant, 2017; 22: 749-754 DOI: 10.12659/AOT.905498 Received: 2017.05.25 Accepted: 2017.07.19 The Evolution of Corneal Transplantation Published: 2017.12.15 Authors’ Contribution: ABCDEF 1 Tobias Röck 1 Centre for Ophthalmology, University of Tübingen, Tübingen, Germany Study Design A DEF 1 Johanna Landenberger 2 Department of General Medicine, Ruhr-University Bochum, Bochum, Germany Data Collection B Statistical Analysis C CDEF 2 Matthias Bramkamp Data Interpretation D ACDEF 1 Karl Ulrich Bartz-Schmidt Manuscript Preparation E ABCDEF 1 Daniel Röck Literature Search F Funds Collection G Corresponding Author: Tobias Röck, e-mail: [email protected] Source of support: Departmental sources Background: The aim of this study was to investigate the evolution of surgical methods in and leading indications for cor- neal transplantation from 2005 to 2016. Material/Methods: Data from the corneal graft waiting list and from all keratoplasties carried out between 2005 and 2016 at the University Eye Hospital Tübingen were retrospectively evaluated. Results: A total of 1259 keratoplasties were performed between 2005 and 2016 at the University Eye Hospital Tübingen. The most common surgical indications for corneal transplantation were Fuchs endothelial corneal dystrophy (45.5%) and keratoconus (14.2%). The mean rate of corneal transplantations almost doubled from 71 kerato- plasties per year in the first 6-year period to 139 keratoplasties per year in the second 6-year period (P=0.005). The number of penetrating keratoplasties remained similar. The number of Descemet membrane endothelial keratoplasties (DMEK) increased significantly from 2008 to 2016 (P<0.0001). One DMEK procedure was per- formed in 2008 (representing 1.4% of all transplantations), while 75 DMEK procedures were performed in 2016 (representing 60.5% of all transplantations) (P<0.0001). DMEK became the favored surgical method for endo- thelial disorders, exceeding penetrating keratoplasty in 2013. Conclusions: Our study shows evolutionary changes in preferred corneal transplantation techniques and leading indications for keratoplasty from 2005 to 2016. Since its introduction a decade ago, DMEK is currently the golden standard in the management of corneal endothelial dysfunction. MeSH Keywords: Corneal Transplantation • Descemet Membrane • Descemet Stripping Endothelial Keratoplasty • Keratoplasty, Penetrating Full-text PDF: https://www.annalsoftransplantation.com/abstract/index/idArt/905498 1924 — 3 26 Indexed in: [Science Citation Index Expanded] [Index Medicus/MEDLINE] 749 [Chemical Abstracts] [Scopus] Röck T. et al.: ORIGINAL PAPER The evolution of corneal transplantation © Ann Transplant, 2017; 22: 749-754 Background Deep anterior lamellar keratoplasty (DALK), and Boston kera- toprosthesis]. Figure 1 shows a schematic overview display- Eduard Zirm performed the first successful corneal transplan- ing: (A) a virgin cornea and (B–F) different keratoplasty pro- tation in 1905 [1]. It is still the most frequent type of trans- cedures: (B) PK, (C) Boston keratoprosthesis, (D) DALK, (E) plantation performed in humans [2]. After Zirm’s milestone in DSAEK, and (F) DMEK. 1905, only a few improvements were made over the next 100 years, involving microscopes, sutures, antibiotics, and corti- The indications for corneal transplantation were obtained costeroids, but there was little change in the surgical tech- from the waiting list at the turn of the respective year. This niques used. However, the first decade of the 21st century study was approved by the Institutional Review Board of saw an explosion in more selective endothelial replacement the University of Tübingen and adhered to the tenets of the techniques [3]. Declaration of Helsinki. In recent years, the improvements in corneal transplantation Statistical analysis techniques have revolutionized corneal transplant surgery. The breakthrough occurred in 2006, when Melles et al. suc- Statistical analysis of the data was conducted using the cessfully introduced a new technique for transplanting isolat- Statistical Packages for the Social Sciences (SPSS 18.0). ed Descemet’s membrane (DM) through a self-sealing tunnel Quantitative variables are expressed as mean ± standard de- incision, which they referred to as DM endothelial keratoplas- viation (SD). P<0.05 was considered to be statistically signifi- ty (DMEK) [3]. cant. Descriptive statistics and graphic representations of the trend of transplantation techniques and indications were pre- In the years before DMEK was first described, different new pared. Yearly rates of corneal transplantation were compared lamellar keratoplasty techniques have been reported, includ- using the t test. ing Descemet stripping endothelial keratoplasty (DSEK) [4] and Descemet stripping automated endothelial keratoplasty (DSAEK) [5]. These procedures, especially DMEK [3,6], provide Results various benefits over penetrating keratoplasty (PK), based on its minimal invasiveness, low rate of rejection, and minimal re- Between 2005 and 2016, 1259 corneal transplantations were fractive shift, with very quick visual improvement [7]. performed at the University Eye Hospital Tübingen. These in- cluded 725 (57.6%) PKs and 534 (42.4%) lamellar keratoplasties In 2006, Darlington et al. performed a review of corneal trans- (LKs). The mean rate of keratoplasties almost doubled from plantation, analyzing data from 1980 to 2004 [8]. They found 71 corneal transplantations per year in the first 6-year period that more than 95% of corneal tissues were used for PK, and to 139 corneal transplantations per year in the second 6-year the major indications were pseudophakic bullous keratopa- period (P=0.005). thy, keratoconus, Fuchs endothelial dystrophy (Fuchs’ dystro- phy), and repeat grafts. Surgical technique Confronted with the new possibilities of lamellar keratoplas- Between 2005 and 2016, the annual numbers of PK remained ty and inspired by the investigation of Darlington et al. [8], similar. Between 2005 and 2007, keratoplasty was only carried we decided to investigate the changes in surgical methods, out in the form of PKs. The first endothelial keratoplasty (EK) the statistics on keratoplasties, and leading indications at the was carried out in 2008 using the DSAEK method. Exclusively, University Eye Hospital Tübingen from 2005 to 2016. 20 DSAEK procedures were carried out from 2008 to 2009. DMEK quickly replaced DSAEK at the University Eye Hospital Tübingen and remained the favored EK technique until now. Material and Methods One DMEK procedure was carried out in 2008 (representing 1.4% of all keratoplasties), while 75 DMEKs were carried out The medical history of all keratoplasties performed between in 2016 (representing 60.5% of all keratoplasties) (P<0.0001). January 2005 and December 2016 at the University Eye Hospital DMEK became the favored surgical method for endothelial Tübingen were retrospectively analyzed. The indications for disorders, exceeding penetrating keratoplasty in 2013. Boston transplantation were categorized according to keratoconus, keratoprosthesis, DALK, and DSAEK were performed in small Fuchs’ dystrophy, bullous keratopathy, trauma, rejection, and numbers during the 12-year period, representing 0.3%, 1.8%, others. The number of keratoplasties was determined annual- and 1.6% of the total keratoplasties, respectively. ly. The yearly numbers of performed keratoplasties were eval- uated on the basis of the surgical method [PK, DSAEK, DMEK, Indexed in: [Science Citation Index Expanded] [Index Medicus/MEDLINE] 750 [Chemical Abstracts] [Scopus] Röck T. et al.: The evolution of corneal transplantation ORIGINAL PAPER © Ann Transplant, 2017; 22: 749-754 A D B E C F Figure 1. Schematic overview displaying: (A) a virgin cornea and (B–F) different keratoplasty procedures: (B) PK, (C) Boston keratoprosthesis, (D) DALK, (E) DSAEK, and (F) DMEK. Figure 2 shows the distribution of corneal transplantations by increased significantly (P<0.0001). Fuchs’ dystrophy was the technique (PK, DSAEK, DMEK, DALK, and Boston keratoprosthe- leading surgical indication for keratoplasty from 2010 to 2016. sis) of the 1259 performed keratoplasties from 2005 to 2016. In 2005, Fuchs’ dystrophy was only the fourth most common indication (8.3%) for corneal transplantation, but in 2016 it Indications for corneal transplantation was the most common (69.5%). The indications for corneal transplantation were obtained from Figure 3 shows the distribution of the corneal graft waiting list the waiting list, which increased from 36 patients in 2005 to 246 with indications (Fuchs’ dystrophy, keratoconus, bullous kera- patients in 2016. During the study period, the leading surgical topathy, trauma, rejection, and others) for corneal transplan- indications for keratoplasties were Fuchs’ dystrophy (45.5%) tation at the turn of the year from 2005 to 2016 in 936 cases. and keratoconus (14.2%). Other indications for corneal trans- plantation were bullous keratopathy (10.4%), trauma (4.3%), rejection (8.9%), and others such as bacterial, fungal, viral or Discussion Acanthamoeba keratitis, and penetrating corneal ulcers due to trophic disease or chemical and thermal burns of the cornea Our study shows the changing trends in corneal transplantation (16.8%). In 2005, keratoconus was the most common indica- methods and leading indications for corneal transplantation tion (41.7%) for corneal transplantation, but in 2016 it was only at the University Eye Hospital in Tübingen from 2005
Recommended publications
  • Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges

    Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges

    E. K. Massey, F. Ambagtsheer, W. Weimar (Eds.) Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges PABST E. K. Massey, F. Ambagtsheer, W. Weimar (Eds.) Ethical, Legal and Psychosocial Aspects of Transplantation Global Challenges PABST SCIENCE PUBLISHERS Lengerich Bibliographic information published by Die Deutsche Nationalbibliothek Die Deutsche Nationalbibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data is available in the Internet at <http://dnb.ddb.de>. This work is subject to copyright. All rights are reserved, whether the whole or part of the mate- rial is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in other ways, and storage in data banks. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a spe- cific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The authors and the publisher of this volume have taken care that the information and recommen- dations contained herein are accurate and compatible with the standards generally accepted at the time of publication. Nevertheless, it is difficult to ensure that all the information given is entirely accurate for all circumstances. The publisher disclaims any liability, loss, or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents of this volume. © 2017 Pabst Science Publishers · D-49525 Lengerich Internet: www.pabst-publishers.de, www.pabst-science-publishers.com E-mail: [email protected] Print: ISBN 978-3-95853-292-2 eBook: ISBN 978-3-95853-293-9 (www.ciando.com) Formatting: µ Printed in Germany by KM-Druck, D-64823 Gross-Umstadt Contents Preface Introduction Emma K.
  • Ethical Issues in Living-Related Corneal Tissue Transplantation

    Ethical Issues in Living-Related Corneal Tissue Transplantation

    Viewpoint Ethical issues in living-related corneal J Med Ethics: first published as 10.1136/medethics-2018-105146 on 23 May 2019. Downloaded from tissue transplantation Joséphine Behaegel, 1,2 Sorcha Ní Dhubhghaill,1,2 Heather Draper3 1Department of Ophthalmology, ABSTRact injury, typically chemical burns, chronic inflamma- Antwerp University Hospital, The cornea was the first human solid tissue to be tion and certain genetic diseases, the limbal stem Edegem, Belgium 2 transplanted successfully, and is now a common cells may be lost and the cornea becomes vascula- Faculty of Medicine and 5 6 Health Sciences, Dept of procedure in ophthalmic surgery. The grafts come from rised and opaque, leading to blindness (figure 1). Ophthalmology, Visual Optics deceased donors. Corneal therapies are now being In such cases, standard corneal transplants fail and Visual Rehabilitation, developed that rely on tissue from living-related donors. because of the inability to maintain a healthy epithe- University of Antwerp, Wilrijk, This presents new ethical challenges for ophthalmic lium. Limbal stem cell transplantation is designed to Belgium 3Division of Health Sciences, surgeons, who have hitherto been somewhat insulated address this problem by replacing the damaged or Warwick Medical School, from debates in transplantation and donation ethics. lost limbal stem cells (LSC) and restoring the ocular University of Warwick, Coventry, This paper provides the first overview of the ethical surface, which in turn increases the success rates of United Kingdom considerations generated by ocular tissue donation subsequent sight-restoring corneal transplants.7 8 from living donors and suggests how these might Limbal stem cell donations only entail the removal Correspondence to be addressed in practice.
  • Juntendo Medical Journal 2017

    Juntendo Medical Journal 2017

    Special Reviews Juntendo Medical Journal 2017. 63(1), 2-7 A New Immunotherapy Using Regulatory T-Cells for High-Risk Corneal Transplantation TAKENORI INOMATA＊ ＊Department of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan Corneal transplantation is the most commonly performed tissue transplantation worldwide. Despite very high (above 90%) survival rates in recipients with nonvascularized and noninflamed graft beds, survival rates significantly decline (under 50%) when grafts are placed onto vascularized or inflamed host beds associated with conditions such as previous graft rejection, infection, or trauma. These results are seen despite treatment with high doses of nonspecific immunosuppressive medications, which often do not promote long-term survival. Therefore, new strategies are required to modulate the immune system without conventional immunosuppressive agents and improve transplant survival in“high-risk”patients with inflamed host beds. Regulatory T-cells (Treg) are key modulators of the immune response and may play a crucial role in a new therapy for high-risk corneal transplantation. Here we introduce the murine high-risk corneal transplantation model and review the implications of Tregs for corneal transplantation. Key words: corneal transplantation, regulatory T-cell, high-risk corneal transplantation, neovascularization Introduction eyeʼs refractive power. The cornea has three layers, including the epithelium, stroma and endothelium, 1. Outline of corneal transplantation divided by Bowmanʼs membrane and Descemetʼs The first corneal transplantation was successfully membrane respectively. Corneal transplantation is performed by Dr. Eduard Zirm in 1905 1). Along with a surgical procedure where a damaged or diseased the growing demand for corneal transplantation, the cornea is replaced by donated corneal tissue. first institutional eye bank was born in New York in Corneal transplantation has evolved into an array of 1944.
  • Chapter 211111

    Chapter 211111

    Corneal transplantation; developments 2.6 Corneal transplantation; developments Corneal transplants are aimed to improve vision or to relieve pain. Other benefits for patients include saving the eyeball in case of a corneal perforation or improving the cosmetic aspect of the eye. The evolution of corneal transplantation has had an impact on 2.6 eye banking, the processing and selection of donor tissue. International developments Despite attempts since the early 1800s285,286 it was not until the beginning of the 20th century that success in corneal transplantation came in sight. In December 1905, in the former Moravia now Czech Republic, the first successful human corneal transplant was performed by Dr Eduard Zirm on a 45 year old farm hand. The patient suffered from lime burns and both corneas were severally scarred in the centre. At present this patient would be considered a poor candidate for corneal transplantation.75,76 His preoperative visual acuity was hand movements in both eyes. The donor was an 11 year old boy. He lost vision following an intraocular metallic foreign body injury. Zirm enucleated the blind eye and used its clear cornea for two 5.0 mm buttons. He removed the tissue with a von Hippel trephine, developed in 1888. Zirm kept the transplants in place with a bridge of conjunctiva sutured over the corneas. One of the grafts failed, the other cleared and 15 weeks after surgery the patient was sent home. A year later an ophthalmologist checking the patient’s visual acuity found it to be 6/36 with a stenopeic disc. The patient lived for 3 years after surgery.
  • Laryngeal Transplantation Report

    Laryngeal Transplantation Report

    The Royal College of Surgeons of England Laryngeal transplantation Laryngeal transplantation WORKING PArtY FINAL REPOrt June 2011 External Affairs [email protected] Published by The Royal College of Surgeons of England 35–43 Lincoln’s Inn Fields London WC2A 3PE www.rcseng.ac.uk/publications/docs The Royal College of Surgeons of England © 2011 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of The Royal College of Surgeons of England. While every effort has been made to ensure the accuracy of the information contained in this publication, no guarantee can be given that all errors and omissions have been excluded. No responsibility for loss occasioned to any person acting or refraining from action as a result of the material in this publication can be accepted by The Royal College of Surgeons of England. Registered charity no. 212808 The cover image of this document is taken from the India proofs of the first edition of Gray’s Anatomy, held in the College archives. Table of contents Foreword 3 Executive summary 3 1 Background 4 2 Laryngeal transplantation 5 Which parts need to be transplanted? 6 Blood supply 6 Nerve supply 6 Functional outcomes of laryngeal transplantation 6 Breathing 6 Swallowing 6 Voice and speech quality 6 Alternative techniques for voice restoration 7 Previous laryngeal transplantations 7 Key references and further reading 7